Utilized for benign prostatic hyperplasia to alleviate urinary symptoms and support improved flow.
Mechanism of Action
Tamsulosin selectively antagonizes alpha-1A adrenoreceptors in the prostate and bladder neck. This causes smooth muscle relaxation, reducing resistance to urinary flow and improving symptoms of prostatic obstruction.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
12–24 hours
Contraindications
Hypersensitivity to tamsulosin, Orthostatic hypotension history, Severe hepatic impairment
Severe Adverse Events
Floppy iris syndrome, Priapism, Syncope — requires immediate medical attention
Information related to Tamsulosin is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
